GAMA
MDCO

Graticule Asia Macro Advisors’s Medicines Co MDCO Stock Holding History

Graticule Asia Macro Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-52,618
Closed -$2.57M – 168
2017
Q1 		$2.57M Buy
52,618
+26,518
+102% +$1.21M 0.15% 90
2016
Q4 		$886K Buy
+26,100
New +$926K 0.11% 87

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Graticule Asia Macro Advisors's MDCO Position: Q2 2017 in Review

Graticule Asia Macro Advisors sold out of Medicines Co (MDCO) in Q2 2017, closing a stake of 52,618 shares — an estimated $2.57M sold.

Graticule Asia Macro Advisors first reported a position in MDCO in Q4 2016 and held it in 2 quarters. The position peaked at $2.57M in Q1 2017. 202 funds tracked by Wall St. Rank hold MDCO as of Q2 2017.

  • Graticule Asia Macro Advisors reported no remaining Medicines Co position as of Q2 2017 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 52,618 Medicines Co shares in Q2 2017, an estimated $2.57M.
  • Graticule Asia Macro Advisors first reported a position in Medicines Co in Q4 2016 and held it in 2 quarters.
  • Graticule Asia Macro Advisors's Medicines Co position peaked at $2.57M in Q1 2017.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q2 2017.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.